Search results

  1. J

    2024 Stanford MECFS meeting

    Any idea why the interest in Filgotinib versus say rinvoq?—both are JAK1 drugs. Rinvoq advertises that it reduces fatigue (presumably in RA).
  2. J

    2024 Stanford MECFS meeting

    Robert Wust talking about PEM. Exercise is NOT good medicine for ME. Muscle abnormalities in PEM. LC and ME groups. Not due to inactivity. Studies muscle biopsies.
  3. J

    2024 Stanford MECFS meeting

    Yes, closed.
  4. J

    2024 Stanford MECFS meeting

    Ok…. Why no talks by Fluge/Mella? Was there a falling out? Also not thrilled to see KDM there.
  5. J

    2024 Stanford MECFS meeting

  6. J

    How to write a good introduction for an ME/CFS paper?

    Mostly agree with these points about overly long introductions. Yes because the general knowledge level about MECFS is much much lower than say MS or Alzheimer’s. However, I do not favor de-emphasizing the role of fatigue in ME/CFS (or think that it is misleading to focus on fatigue). For me...
  7. J

    ME and PEM recovery via Cyclophosphamide (personal story)

    But there is no planned phase 3 trial for cyclophosphamide. So if you want “robust evidence” it may never happen.
  8. J

    Dr Ron Davis - Updates on ME/CFS research - September 2019 onwards

    Janet Dafoe This was at a hearing with three speakers who spoke for about a half an hour each and at the end the public got to talk. Ron had two minutes. He couldn’t explain the whole model and he couldn’t explain all the details!
  9. J

    Dr Ron Davis - Updates on ME/CFS research - September 2019 onwards

    Ron Davis today at the Santa Clara County ME hearing: “..we think this disease is initiated when you initiate innate immunity…you can turn it back off by JAK-STAT Inhibitor…we have seen 1 patient in Australia who took it..within 3 days of taking the drug was completely cured..”
  10. J

    The current state of ME/CFS research, and its prospects

    The Tweet by Elle Davin is very good actually. More like this please! If I was Vinod, I would use my wealth to fund much more MECFS research. But by replying to him on X it shows him that many more people are interested in MECFS research and maybe pressurizes him to fund more.
  11. J

    News from The Netherlands

    Sad video Anil Van Der Zee A short segment about what it's like to have a relationship and #longcovid. This bit broke my heart. English subtitles included. You can watch the entire episode here:
  12. J

    News from the USA, United States of America

    Doesn’t mention ME/CFS, of course. Journalistic malpractice!
  13. J

    Ozempic, tirzepatide and other GLP-1RAs - impact on ME/CFS

    For UK people—does NHS give you GLP1 drugs for free?
  14. J

    Ozempic, tirzepatide and other GLP-1RAs - impact on ME/CFS

    https://www.cnn.com/2024/08/27/health/zepbound-tirzepatide-new-vials/index.html Lilly launches lower-price weight loss drug without injector pen Only 2.5 and 5mg doses
  15. J

    The staggering death toll of scientific lies

    Scientific fraud kills people. Should it be illegal? https://www.vox.com/future-perfect/368350/scientific-research-fraud-crime-jail-time
  16. J

    Cyclophosphamide for myasthenia gravis: a comeback?

    https://jnnp.bmj.com/content/early/2024/07/04/jnnp-2024-333920 this study shows that lower doses of cyclophosphamide can be effective and safe in people with MG, including older age. Clinicians may consider low-dose cyclophosphamide as a safe and cost-effective intervention in carefully...
  17. J

    Persistent Autonomic and Immunologic Abnormalities in Neurologic Post-Acute Sequelae of SARS-CoV2 Infection, 2024, Goldstein, Walitt, Nath+

    I think it’s better than nothing. If something is really out of whack, it will show up even in a small sample.
  18. J

    Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies Minhas 2024

    It’s this—there is human data actually A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma https://pubmed.ncbi.nlm.nih.gov/32436060/
  19. J

    Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies Minhas 2024

    https://scitechdaily.com/stanford-reverses-cognitive-decline-in-alzheimers-with-brain-metabolism-drug/ Stanford Reverses Cognitive Decline in Alzheimer’s With Brain Metabolism Drug
Back
Top Bottom